MICHAEL SWABASH: Open Payments
NPI 1922630763 · LAPEER, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,310 in 65 payments from 14 companies in 2025. Trend: 2023 $2,410 · 2024 $761 · 2025 $1,310
Food & beverage: $1,145Education: $165
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $311 |
| UCB, Inc. | 6 | $215 |
| E.R. Squibb & Sons, L.L.C. | 17 | $213 |
| GENZYME CORPORATION | 7 | $148 |
| Amgen Inc. | 4 | $84 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| Organon LLC | 3 | $72 |
| ABBVIE INC. | 3 | $60 |
| Galderma Laboratories, L.P. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
Products named: TREMFYA, DUPIXENT, Bimzelx, Sotyktu, OTEZLA, SKYRIZI, NEMLUVIO, SPEVIGO.
Industry payments across MI — which companies pay providers there.
